Page 292 - Read Online
P. 292

Page 8 of 9                                                  Pasini et al. Hepatoma Res 2020;6:26  I  http://dx.doi.org/10.20517/2394-5079.2019.47

                   2012;19:2515-25.
               33.  Minagawa M, Makuuchi M, Takayama T, Kokudo N. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular
                   carcinoma. Ann Surg 2003;238:703-10.
               34.  Roayaie S, Bassi D, Tarchi P, Labow D, Schwartz M. Second hepatic resection for recurrent hepatocellular cancer: a Western experience.
                   J Hepatol 2011;55:346-50.
               35.  Zou Q, Li J, Wu D, Yan Z, Wan X, et al. Nomograms for pre-operative and post-operative prediction of long-term survival of patients
                   who underwent repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg Oncol 2016;23:2618-26.
               36.  Chan DL, Morris DL, Chua TC. Clinical efficacy and predictors of outcomes of repeat hepatectomy for recurrent hepatocellular
                   carcinoma - a systematic review. Surg Oncol 2013;22:e23-30.
               37.  Huang ZY, Liang BY, Xiong M, Zhan DQ, Wei S, et al. Long-term outcomes of repeat hepatic resection in patients with recurrent
                   hepatocellular carcinoma and analysis of recurrent types and their prognosis: a single-center experience in China. Ann Surg Oncol
                   2012;19:2515-25.
               38.  Faber W, Seehofer D, Neuhaus P, Stockmann M, Denecke T, et al. Repeated liver resection for recurrent hepatocellular carcinoma. J
                   Gastroenterol Hepatol 2011;26:1189-94.
               39.  Kubo S, Takemura S, Uenishi T, Yamamoto T, Ohba K, et al. Second hepatic resection for recurrent hepatocellular carcinoma in patients
                   with chronic hepatitis C. World J Surg 2008;32:632-8.
               40.  Itamoto T, Nakahara H, Amano H, Kohashi T, Ohdan H, et al. Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery
                   2007;141:589-97.
               41.  Tralhão JG, Dagher I, Lino T, Roudié J, Franco D. Treatment of tumour recurrence after resection of hepatocellular carcinoma. Analysis
                   of 97 consecutive patients. Eur J Surg Oncol 2007;33:746-51.
               42.  Kobayashi A, Kawasaki S, Miyagawa S, Miwa S, Noike T, et al. Results of 404 hepatic resections including 80 repeat hepatectomies for
                   hepatocellular carcinoma. Hepatogastroenterology 2006;53:736-41.
               43.  Sugimachi K, Maehara S, Tanaka S, Shimada M, Sugimachi K. Repeat hepatectomy is the most useful treatment for recurrent
                   hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2001;8:410-6.
               44.  Hu RH, Lee PH, Yu SC, Dai HC, Sheu JC, et al. Surgical resection for recurrent hepatocellular carcinoma: prognosis and analysis of risk
                   factors. Surgery 1996;120:23-9.
               45.  Cai W, Liu Z, Xiao Y, Zhang W, Tang D, et al. Comparison of clinical outcomes of laparoscopic versus open surgery for recurrent
                   hepatocellular carcinoma: a meta-analysis. Surg Endosc 2019;33:3550-7.
               46.  Halls MC, Berardi G, Cipriani F, Barkhatov L, Lainas P, et al. Development and validation of a difficulty score to predict intraoperative
                   complications during laparoscopic liver resection. Br J Surg 2018;105:1182-91.
               47.  Majno PE, Sarasin FP, Mentha G, Hadengue A. Primary liver resection and salvage transplantation or primary liver transplantation in
                   patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology
                   2000;31:899-906.
               48.  Kostakis ID, Machairas N, Prodromidou A, Stamopoulos P, Garoufalia Z, et al. Comparison between salvage liver transplantation and
                   repeat liver resection for recurrent hepatocellular carcinoma: a systematic review and meta-analysis. Transplant Proc 2019;51:433-6.
               49.  Lim C, Shinkawa H, Hasegawa K, Bhangui P, Salloum C, et al. Salvage liver transplantation or repeat hepatectomy for recurrent
                   hepatocellular carcinoma: An intent-to-treat analysis. Liver Transpl 2017;23:1553-63.
               50.  Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma
                   on cirrhosis: a reasonable strategy? Ann Surg 2003;238:508-18.
               51.  Wang HL, Mo DC, Zhong JH, Ma L, Wu FX, et al. Systematic review of treatment strategy for recurrent hepatocellular carcinoma:
                   Salvage liver transplantation or curative locoregional therapy. Medicine (Baltimore) 2019;98:e14498.
               52.  Lucidi V, Gustot T, Moreno C, Donckier V. Liver transplantation in the context of organ shortage: toward extension and restriction of
                   indications considering recent clinical data and ethical framework. Curr Opin Crit Care 2015;21:163-70.
               53.  Taura K, Ikai I, Hatano E, Fujii H, Uyama N, et al. Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged
                   survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old. Ann Surg
                   2006;244:265-73.
               54.  Lü MD, Kuang M, Liang LJ, Xie XY, Peng BG, et al. Surgical resection versus percutaneous thermal ablation for early-stage
                   hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi 2006;86:801-5. (in Chinese)
               55.  Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, et al. A prospective randomized trial comparing percutaneous local ablative therapy and
                   partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006;243:321-8.
               56.  Chan AC, Poon RT, Cheung TT, Chok KS, Chan SC, et al. Survival analysis of re-resection versus radiofrequency ablation for
                   intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. World J Surg 2012;36:151-6.
               57.  Gavriilidis P, Askari A, Azoulay D. Survival following redo hepatectomy vs radiofrequency ablation for recurrent hepatocellular
                   carcinoma: a systematic review and meta-analysis. HPB (Oxford) 2017;19:3-9.
               58.  Thomasset SC, Dennison AR, Garcea G. Ablation for recurrent hepatocellular carcinoma: a systematic review of clinical efficacy and
                   prognostic factors. World J Surg 2015;39:1150-60.
               59.  Wang K, Liu G, Li J, Yan Z, Xia Y, et al. Early intrahepatic recurrence of hepatocellular carcinoma after hepatectomy treated with re-
                   hepatectomy, ablation or chemoembolization: a prospective cohort study. Eur J Surg Oncol 2015;41:236-42.
               60.  Malagari K, Alexopoulou E, Chatzimichail K, Hall B, Koskinas J, et al. Transcatheter chemoembolization in the treatment of HCC in
                   patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead. Abdom Imaging 2008;33:512-9.
   287   288   289   290   291   292   293   294   295   296   297